Lili Zhang

Lili Zhang

Company: Aprinoia Therapeutics Inc.

Job title: Senior Vice President & Head of Preclinical Development


Targeted Protein Degradation of Tau & Alpha-Synuclein For Preventing Neurodegeneration in Alzheimer’s & Parkinson’s Disease 1:30 pm

Harnessing protein degradation technology using dual function target binders and E3-ligase ligands to degrade pathological protein aggregates via the ubiquitinproteasome system Investigating selectivity and specificity of mechanism of action in cells and in vivo Using proprietary diagnostic radiotracers to select patients and provide both target engagement and efficacy readoutsRead more

day: Clinical & Commercial Track PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.